Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Autoimmune hepatitis.

D Vergani1, G Mieli-Vergani

  • 1Institute of Liver Studies, King's College Hospital, London, UK. diego.vergani@kcl.ac.uk

Minerva Gastroenterologica E Dietologica
|February 22, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Real-world management of juvenile autoimmune liver disease.

United European gastroenterology journal·2018
Same author

Interferon-free therapy in hepatitis C virus mixed cryoglobulinaemia: a prospective, controlled, clinical and quality of life analysis.

Alimentary pharmacology & therapeutics·2018
Same author

Spectroscopic identification of r-process nucleosynthesis in a double neutron-star merger.

Nature·2017
Same author

Immunosuppressive drugs affect interferon (IFN)-γ and programmed cell death 1 (PD-1) kinetics in patients with newly diagnosed autoimmune hepatitis.

Clinical and experimental immunology·2017
Same author

Autoimmune hepatitis: From mechanisms to therapy.

Revista clinica espanola·2016
Same author

HBsAg plasma level kinetics: a new role for an old marker as a therapy response predictor in vertically infected children on combination therapy.

Journal of viral hepatitis·2014
Same journal

Hepatic steatosis integrated approach: nutritional guidelines and joined nutraceutical administration.

Minerva gastroenterologica e dietologica·2021
Same journal

Diagnostic accuracy of computerized tomography (CT) angiography in detecting non-variceal gastrointestinal bleeding (NVGIB): a sistematic review.

Minerva gastroenterologica e dietologica·2020
Same journal

Helicobacter pylori and non-alcoholic fatty liver disease.

Minerva gastroenterologica e dietologica·2020
Same journal

Hypertriglyceridemic pancreatitis.

Minerva gastroenterologica e dietologica·2020
Same journal

Effectiveness of percutaneous endoscopic gastrostomy in amyotrophic lateral sclerosis.

Minerva gastroenterologica e dietologica·2020
Same journal

Noninvasive diagnosis of fibrosis in non-alcoholic fatty liver disease: diagnostic accuracy of different scores.

Minerva gastroenterologica e dietologica·2020
See all related articles

Autoimmune hepatitis (AIH) is an immune condition affecting the liver, often mimicking acute hepatitis. Early immunosuppressive treatment is crucial for managing both type 1 and type 2 AIH, which differ in autoantibody profiles and genetic susceptibility.

Area of Science:

  • Hepatology
  • Immunology
  • Gastroenterology

Background:

  • Autoimmune hepatitis (AIH) is a chronic liver disease characterized by interface hepatitis, autoantibodies, and elevated immunoglobulin G.
  • AIH onset can be insidious, often presenting similarly to acute hepatitis.
  • Two main types are recognized: Type 1 AIH (SMA/ANA positive) and Type 2 AIH (LKM1 positive).

Purpose of the Study:

  • To summarize the key characteristics, serological distinctions, genetic predispositions, and potential pathogenesis of autoimmune hepatitis.
  • To highlight the importance of timely diagnosis and immunosuppressive treatment for AIH management.

Main Methods:

  • Histological examination for interface hepatitis.
  • Serological testing for autoantibodies (SMA, ANA, LKM1).

Related Experiment Videos

  • Genetic analysis for HLA associations (DR3, DR4, DR7).

    • Main Results:

    • Type 1 AIH is associated with HLA DR3/DR4, while Type 2 AIH is linked to HLA DR7.
    • Type 2 AIH patients may present more acutely, younger, and often have IgA deficiency.
    • Both types show female predominance and similar treatment responses and prognoses.

    Conclusions:

    • AIH pathogenesis likely involves immune reactions to liver antigens, possibly triggered by molecular mimicry and perpetuated by immune dysregulation.
    • Prompt immunosuppressive therapy is essential upon diagnosis for effective AIH management.
    • Understanding AIH subtypes and genetic factors aids in diagnosis and potentially personalized treatment approaches.